2024 Investor Day · page 42 of 62
The slide uses a drill-down visual to show that 94% of revenue comes from Biopharma, which is then split into Top 20 (50%), Enterprise (15%), and SMB (35%).
Consulting deck · segmentation · decompose_segments · balanced density
Slide locked Sign in to view
Slide schematic 4/5
chart 1/1 diagram 1/1 disclaimer 1/1 metric 0/1 title 1/1
1 without position metric 1
metric · primary
Components 5
bar-horizontal process disclaimer primary headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1